pubmed-article:10333912 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C0246689 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
pubmed-article:10333912 | lifeskim:mentions | umls-concept:C1883712 | lld:lifeskim |
pubmed-article:10333912 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:10333912 | pubmed:dateCreated | 1999-7-13 | lld:pubmed |
pubmed-article:10333912 | pubmed:abstractText | To compare the effect of repaglinide in combination with metformin with monotherapy of each drug on glycemic control in patients with type 2 diabetes. | lld:pubmed |
pubmed-article:10333912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:language | eng | lld:pubmed |
pubmed-article:10333912 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10333912 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10333912 | pubmed:month | Jan | lld:pubmed |
pubmed-article:10333912 | pubmed:issn | 0149-5992 | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:MosesRR | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:CarterJJ | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:HopkinsHH | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:SlobodniukRR | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:KidsonWW | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:MoffittPP | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:ColagiuriSS | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:DonnellyTT | lld:pubmed |
pubmed-article:10333912 | pubmed:author | pubmed-author:BoyagesSS | lld:pubmed |
pubmed-article:10333912 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10333912 | pubmed:volume | 22 | lld:pubmed |
pubmed-article:10333912 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10333912 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10333912 | pubmed:pagination | 119-24 | lld:pubmed |
pubmed-article:10333912 | pubmed:dateRevised | 2008-10-1 | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:meshHeading | pubmed-meshheading:10333912... | lld:pubmed |
pubmed-article:10333912 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10333912 | pubmed:articleTitle | Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes. | lld:pubmed |
pubmed-article:10333912 | pubmed:affiliation | Department of Endocrinology, Illawarra Regional Hospital, Wollongong, Australia. robert_moses@uow.edu.au | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:10333912 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10333912 | lld:pubmed |